Shionogi & Co.

Shionogi & Co. is a global pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of innovative pharmaceutical products. The company primarily focuses on leveraging its scientific expertise and research capabilities to create new therapeutic options for infectious diseases, pain, and central nervous system disorders. Their integrated approach emphasizes a strong research and development pipeline to address complex medical challenges.

The company was founded in 1878 by Gisaburo Shiono, Sr., who established Shiono Gisaburo Shoten as a drug wholesaler in Osaka, Japan. Shiono's initial insight was to supply essential pharmaceutical products, evolving his venture from distribution into a prominent research-intensive pharmaceutical enterprise. This marked the inception of Shionogi's sustained commitment to medical innovation and public health.

Shionogi's medicines serve healthcare providers and patients across various therapeutic areas, aiming to improve global health outcomes. The company's vision is rooted in continuously contributing to patient well-being by pioneering novel pharmaceutical solutions. They strive to be a leader in tackling unmet medical needs, driven by a forward-looking perspective on scientific and medical advancement.